Middle East and Africa Protein Chip Market is segmented By Technology (Analytical Microarrays, Functional Protein Microarrays, Reverse Phase Protein Microarrays), By Application (Diagnostics, Proteomics, Antibody Characterization), By End-User (Hospital & Clinics, Diagnostic Laboratories, Academic & Research Institutes, Pharmaceuticals & Biotechnological Companies), and By Country (KSA, UAE, Saudi Arabia, South Africa, and Rest of Middle East and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Middle East and Africa Protein Chip Market Overview
The Middle East and Africa Protein Chip Market is expected to grow at a CAGR of 17.8% during the forecast period 2023-2030.
Protein microarrays, also known as protein chips, are high-density parallel assay systems containing small amounts of proteins. Protein chips play an important function in diagnostics. With the help of these chips, healthcare providers can check the level of infection for a particular disease or disorder.
Protein chips have been extensively employed in healthcare and biological industries to conduct fundamental research. Furthermore, these chips have been used in drug development research initiatives including contagious and lethal disorders. Protein chips are made comprised of a support surface, such as a glass slide or microtitre plate, that aids in the capture of protein in use, and these molecules are then labelled and assembled in a dye of a certain colour and added to the array. Any interaction between them is then signalled and recorded for future experimentation.
Middle East and Africa Protein Chip Market Scope
|
Metrics |
Details |
|
CAGR |
17.8% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Technology, Application, and End User |
|
Countries Covered |
KSA, UAE, Saudi Arabia, South Africa, and Rest of Middle East and Africa |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report - Request for Sample
Market Key Drivers
A protein chip is used to monitor protein activity and interactions in the body. Furthermore, it is expected that growing awareness of tailored medications would aid market expansion. The rising cancer incidence rate, the biopharmaceutical industry's research for successful drugs, recent technological advancements in gene and protein studies, and the increasing use of advanced technologies in diagnostic testing are the main drivers that will continue to drive the MEA protein chip market. Cancer is one of the top causes of mortality globally, with over 10 million deaths expected in 2020, according to the World Health Organization. Over 10500 fatalities and 24,500 new cancer cases were recorded in Saudi Arabia in 2018. With early identification and therapy, protein biochips may help decrease cancer mortality.
As protein arrays have various applications, such as cancer detection and protein interaction tests for specialized clinical diagnostics, increasing investment in research and development of protein biochips is driving the market over time. Many firms use mass spectrometry, and manufacturers and labs interact with protein chip companies. increasing demand for tailored pharmaceuticals, as well as increasing R&D in proteomics, are projected to fuel the MEA protein chip market expansion.
Segmentation Analysis
The Middle East and Africa Protein Chip Market is segmented by technology, application, and end user.
Based on technology, the functional protein microarray segment is expected to have the largest share of the market during the projection period, owing to its widespread use in sophisticated diagnostics. High-throughput investigation of protein interactions, protein-protein binding, enzyme activity, and post-translational changes is possible using functional protein microarrays. This thorough knowledge helps with drug development, biomarker identification, and comprehension of complicated biological circuits. The relevance of the sector in customized medicine and diagnostics, where it permits the evaluation of unique reactions to treatments, contributes to its popularity.
Regional Insights
By Region, the Middle East and Africa Protein Chip Market is segmented into KSA, UAE, Saudi Arabia, South Africa, and Rest of Middle East and Africa.
Geographically, the Saudi Arabian protein chip market is expected to develop at a modest CAGR during the projected period and maintain its dominance in this region. The rise in the population impacted by a rising number of infectious illnesses, technologically enhanced products, expanding public awareness of customized medicine, and increased public knowledge of targeted drug delivery treatments for cancer medicines are driving market growth. Furthermore, the booming medicinal and biotechnology sectors will drive up market demand for protein chips.
The African area is expected to increase at a consistent pace, owing to an increasing population afflicted by rising infection rates, a high cancer incidence, and a growing demand for technical improvements. As a result, it is expected that these factors would aid the MEA protein chip market's growth, particularly in the South African regional market. Moreover, with the government's expanding initiative, it is expected that the industry will witness future development potential.
Middle East and Africa Protein Chip Market Key Companies
Companies playing a prominent role in the Middle East and Africa protein chip market are SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc., EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
